Chung‐Hsin Chen
Impact in
- Pharmacology top 1%
- Drug-Induced Hepatotoxicity and Protection
-
- Nephrotoxicity and Medicinal Plants
Papers in
-
- Prostate Cancer Diagnosis and Treatment 23
- Prostate Cancer Treatment and Research 19
- Renal cell carcinoma treatment 6
- Surgery 34
- Bladder and Urothelial Cancer Treatments 27
- Urinary and Genital Oncology Studies 6
- Co-authors
- Yeong‐Shiau Pu (59 shared papers)Kathleen G. Dickman (9 shared papers)Chao‐Yuan Huang (39 shared papers)Arthur P. Grollman (8 shared papers)Robert J. Turesky (5 shared papers)Masaaki Moriya (4 shared papers)Viktoriya S. Sidorenko (4 shared papers)Kuo‐How Huang (20 shared papers)
- Journals
- Scientific Reports (6 papers)Cancers (5 papers)Cryobiology (4 papers)Urologic Oncology Seminars and Original Investigations (4 papers)Frontiers in Oncology (4 papers)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Chung‐Hsin Chen
100 papers receiving 2.6k citations
Chung‐Hsin Chen's Hit Papers
Peers
Comparison fields: 5 of 113
- Pharmacology 281
- Radiology, Nuclear Medicine and Imaging 639
- Cancer Research 281
- Surgery 732
- Analytical Chemistry 176
Countries citing papers authored by Chung‐Hsin Chen
This map shows the geographic impact of Chung‐Hsin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Hsin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Hsin Chen more than expected).
Fields of papers citing papers by Chung‐Hsin Chen
This network shows the impact of papers produced by Chung‐Hsin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Hsin Chen. The network helps show where Chung‐Hsin Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Chung‐Hsin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Aristolochic acid-associated urothelial cancer in Taiwan Hit paper breakdown → | 2012 | 351 |
| 2 | 2013 | 220 | |
| 3 | Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2022 | 210 |
| 4 | 2007 | 153 | |
| 5 | 2018 | 152 | |
| 6 | 2007 | 116 | |
| 7 | 2013 | 106 | |
| 8 | 2007 | 96 | |
| 9 | 2017 | 93 | |
| 10 | 2012 | 87 | |
| 11 | 2021 | 73 | |
| 12 | 2016 | 68 | |
| 13 | 1999 | 57 | |
| 14 | 2007 | 46 | |
| 15 | 2014 | 43 | |
| 16 | 2017 | 40 | |
| 17 | 2010 | 36 | |
| 18 | 2008 | 35 | |
| 19 | 2013 | 29 | |
| 20 | 2022 | 25 |
About Chung‐Hsin Chen
Chung‐Hsin Chen is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Radiology, Nuclear Medicine and Imaging, Rheumatology and Cancer Research, having authored 105 papers that have together received 2.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (27 papers), Prostate Cancer Diagnosis and Treatment (23 papers), Prostate Cancer Treatment and Research (19 papers), Nephrotoxicity and Medicinal Plants (9 papers), Urologic and reproductive health conditions (6 papers), Renal cell carcinoma treatment (6 papers), Urinary and Genital Oncology Studies (6 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Pharmacology (281 citations), Radiology, Nuclear Medicine and Imaging (639 citations), Cancer Research (281 citations), Surgery (732 citations) and Analytical Chemistry (176 citations). Chung‐Hsin Chen has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Yeong‐Shiau Pu, Kathleen G. Dickman, Chao‐Yuan Huang, Arthur P. Grollman, Robert J. Turesky, Masaaki Moriya, Viktoriya S. Sidorenko, Kuo‐How Huang, Chia‐Tung Shun and Hong‐Jeng Yu. Their work appears in journals such as Scientific Reports, Cancers, Cryobiology, Urologic Oncology Seminars and Original Investigations and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.